Summary
The product Trenbolone Acetate, manufactured by Endura Biosciences CO., LTD, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number 001, was submitted by the manufactuer Endura-Biosciences@proton.me and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Trenbolone Acetate, with a concentration of 105.16 mg/ml, exceeding the typical labeled claim of 100 mg/ml by 5.16%.
The testing process was conducted on 15 July 2024. While the results confirm accurate dosing, scrutiny of manufactuer-submitted samples is essential to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Endura Biosciences CO., LTD
- Product Name: Trenbolone Acetate
- Active Ingredient: Trenbolone Acetate
- Batch Number: 001
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #45351
- Testing Ordered: 4 July 2024
- Sample Received: 12 July 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Endura Biosciences (Manufacturer)
- Analysis Paid For By: Endura Biosciences (Manufacturer)
Testing Results
- Specification: 100 mg/ml (typical label claim)
- Measured Concentration: 105.16 mg/ml
- Accuracy: 105.16% (5.16% above the typical label claim)
- Variance: 5.16
Verification Details
- Verification URL: https://janoshik.com/tests/45351_YD1QK3PP3HKQ
Evaluation of Manufactuer-Submitted Testing
This analysis highlights the accuracy of the tested product but warrants careful evaluation due to its submission by the manufactuer. Manufactuer may select specific batches for testing, which may not fully represent the consistency of products available to consumers. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion
The analysis confirms that Trenbolone Acetate is slightly overdosed, with a measured concentration of 105.16 mg/ml. This result reflects strong quality control for this batch but underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufactuer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
